We have studied the effects of dexamethasone and prednisolone in vitro and in vivo on insulin binding, deoxyglucose uptake and glucose oxidation in rat adipocytes. In the studies in vivo, rats were treated for 22 h with dexamethasone (30 ~tg/kg) or prednisolone (200 ~tg/kg). Following sacrifice, adipocytes were prepared and the results demonstrated that cells from prednisolone treated rats showed a 17% increase in insulin binding and increased rates of basal and insulin stimulated deoxyglucose uptake and glucose oxidation. Conversely, dexamethasone administration resulted in a 22% decrease in insulin binding, and decreased rates of deoxyglucose uptake and glucose oxidation by the cells. Thus, prednisolone and dexamethasone had opposite effects in vivo. In contrast to the opposite effects of the two glucocorticoids in vivo, dexamethasone and prednisolone (each at a concentration of 1 ~mol/1) had similar effects on adipocytes in vitro. Incubation of adipocytes with the steroids did not alter insulin binding, while both agents led to a comparable decrease in the rates of basal and insulin stimulated deoxyglucose uptake and glucose oxidation. Thus, dexamethasone and prednisolone have opposite effects on adipocyte glucose metabolism in vivo but have similar effects in vitro.
Insulin resistance is a well documented consequence of glucocorticoid administration both in man [1, 2] and rats [3, 4] . One cause of this insulin resistance is the well known effect Of these drugs to inhibit tissue I Present address: 2 Clinica Medica, Policlinico Umberto 1, 1-00145 Roma, Italy glucose uptake and metabolism [5] . In addition to their effects on glucose metabolism, administration of glucocorticoids in vivo may also impair insulin binding to target cells, and this could provide another cause for glucocorticoid-induced insulin resistance. The results of several studies support this hypothesis. Thus, it has been demonstrated that treatment of rats with dexamethasone decreases the insulin binding capacity of hepatocytes and adipocytes [6, 7] . However, Beck-Nielsen et al. [8] have demonstrated that administration of prednisone in man produces an increase in the insulin binding capacity of circulating monocytes. These apparently conflicting results raise the possibility that different glucocorticoids can produce divergent effects on both insulin binding and glucose metabolism. In order to test this hypothesis we have studied the effects of prednisolone and dexamethasone on insulin binding and insulin action on rat adipocytes both in vivo and in vitro.
Materials and Methods

Materials
Porcine highly-purified insulin was generously supplied by Dr. Ronald Chance of Eli Lilly, Indianapolis. Bovine serum albumin (fraction V) was purchased from Armour, Phoenix, Arizona; col- 
Animals
Male Sprague-Dawley rats (160-170 g) were used for all experiments. Animals were injected SC three times (at 1500, 2300 and 0700h) with saline (0.154mol/I), dexamethasone (30 [xg/kg) or prednisolone (200 ~tg/kg) and then stunned by a blow to the head and decapitated at 1300 h. Thus, each rat was killed 6 h after the last injection (22 h after the first injection). The injection volume was 0.4 ml and steroids were freshly prepared from stock solutions in ethanol by drying the desired amount under nitrogen and resuspending in saline. All rats had free access to standard rat chow and water. No weight differences were found between any of the groups.
Preparation of Isolated Adipocytes
Isolated fat cells were prepared from epididymal fat pads by shaking at 37 ~ for 60 rain in Krebs-Ringer bicarbonate buffer (pH 7.4) containing collagenase (3 mg/ml) and bovine serum albumin (BSA) (40 mg/ml) according to the method of Rodbell [9] . Cells were filtered through 250 ~tM nylon mesh, centrifuged at 400 rev/ min for 4 min and washed twice in buffer. Adipocyte counts were performed according to a modification of method III of Hirsch and Gallian [10] in which the cells were fixed in 2% osmium tetroxide in 0.05 mol/1 collidine buffer (made up to physsiological osmolality with saline) for 24 h at 37 ~ and then taken up in a known volume of 0.154 mmol/1 NaC1 for counting with a Coulter Counter Model ZB.
This assay measures the total uptake of the radiolabelled 2-deoxyglucose and is based on the principle that, although 2-deoxyglucose can be phosphorylated like D-glucose, it cannot be further metabolised [17] . The assay was terminated at the end of 3 min by transferring 200 ~d aliquots from the assay mixture to plastic microtubes containing 100 ~tl silicone oil. The tubes were centrifuged for 30 s in a Beckman microfuge, and the assay was considered terminated when centrifugation begins. In experiments in which the stimulatory effect of insulin on uptake was measured, the cells were preincubated with insulin for 60 min at 24 ~ The amount of sugar trapped in the extracellular water space of the cell layers was determined using L-[1-3H]-glucose, and was 0.033 _+ 0.001% (mean _+ SEM).
Glucose Oxidation
The ability of adipocytes to oxidize glucose was determined according to the method of Rodbell [9] . Adipocytes were incubated at 37 ~ with [1J4C]-glucose (2 retool/l) in Krebs-Ringer bicarbonate buffer (pH 7.4) containing BSA (40 mg/ml). After 1 h of incubation the generated a4CO2 was collected and counted in a liquid scintillation counter.
Analytical Methods
Plasma glucose was determined by the glucose oxidase method using a Beckman glucose analyser. Plasma insulin was determined by the double antibody radioimmunoassay [ 18] , and non-esterified fatty acid (NEFA) by the method of Chlouverakis and Hojnicki [19] .
Statistical Analysis
Results are presented as mean _+ SEM. Analysis of variance was used to test for significant changes.
Iodination of Insulin
[125I]insulin was prepared at a specific activity of 170-190 ~tCi/~tg according to a modification [11] of the method of Hunter and Greenwood [12] .
Binding Studies
Isolated fat cells were suspended in a buffer containing 35 mmol/1 Tris, 120mmol/1 NaC1, 1.2mmol/1 MgSO4, 5mmol/1 KC1, 10 mmol/1 glucose, 2 mmol/1 CaC12; 24 retool/1 Na acetate and 10mg/ml BSA, pH 7.6, and incubated with [125I]insulin and unlabelled insulin in plastic flasks in a 24 ~ shaking water bath as previously described [13] . Optimal steady-state binding conditions are achieved at 24 ~ after 60 min of incubation. The incubations were terminated by removing 200 ~tl aliquots from the cell suspension and rapidly centrifuging the cells in plastic microtubes to which 100 ~tl silicone oil had been added [14] . The cells were then removed and the radioactivity determined. All studies were carried out in triplicate.
Results
Studies in Vivo
The effects of 22 h dexamethasone or prednisolone treatment on plasma glucose, NEFA and insulin concentrations are presented in Table 1 . As can be seen, dexamethasone treatment led to an increase, whilst prednisolone led to a decrease in plasma insulin concentration. Neither steroid had any statistically significant effect on plasma glucose concentration, whereas plasma NEFA concentrations were elevated in both treatment groups. It should be noted that food intake and body weight were the same in controls and both experimental groups over the treatment period.
2-Deoxyglucose Uptake
These studies were performed using the same cell centrifugation technique as described for the binding studies, and the details of this method have been previously reported [15, 16] . Unless otherwise stated, isolated adipocytes were incubated with 2-deoxy- Insulin binding was studied over a range of insulin ~ 1.0-concentrations and the resulting competition curves are shown in Figure 1 a. The shapes of these curves ~ 0.5-were comparable and treatment with the different glucocorticoids led to opposite effects on insulin 0-binding at each insulin concentration. Scatchard plots of these insulin binding data are shown in Fig. 1 b. The curves are generally parallel, whilst the intercepts or the abscissa are different, suggesting that the alterations in insulin binding are due to changes in the number of insulin receptors per cell, rather than to changes in affinity.
2-Deoxyglucose Uptake." The effect of insulin on 2-deoxyglucose uptake by adipocytes from control and glucocorticoid treated rats is shown in Fig. 2 . It can be seen that dexamethasone administration resulted in decreased rates of uptake at all insulin concentrations. Prednisolone produced the opposite effect; that is uptake was increased at all insulin concentrations.
Glucose Oxidation: The effects of administration of the glucocorticoids on glucose oxidation were similar to those on 2-deoxyglucose uptake (Fig. 3) . Again, the effect of prednisolone was opposite to that of dexamethasone. Thus, basal and insulin stimulated glucose oxidation were increased by prednisolone, but decreased by dexamethasone.
Studies in Vitro
Insulin Binding: Adipocytes were incubated with dexamethasone or prednisolone (1 gmol/1) for 2, 4, or 6 h. Neither of the steroids altered the insulin binding capacity of the cells (results not shown).
Glucose Oxidation: Figure 4 shows the effect of insulin on glucose oxidation by adipocytes which had been incubated with the glucocorticoids. It can be seen that both steroids decreased the rates of oxidation in the absence of insulin, and at all insulin concentrations tested.
2-Deoxyglucose Uptake:
Dexamethasone and prednisolone produced similar effects in vitro on 2-deoxyglucose uptake to those described above for glucose oxidation. Thus, both glucocorticoids decreased the rates of basal and insulin stimulated 2-deoxyglucose uptake by the cells (data not shown). Statistical analysis showed that control versus prednisolone and control versus dexamethasone was significantly different at each insulin concentration tested (p <0.01)
Discussion
The results reported in this paper demonstrate that administration of dexamethasone and prednisolone have markedly differing effects on insulin binding and on the ability of insulin to stimulate glucose metabolism in adipocytes. Cells from rats treated with dexamethasone showed a decreased capacity to bind insulin, and Scatchard analysis suggested that this was due to a decreased number of insulin receptors. These cells also showed decreased rates of basal and insulin stimulated deoxyglucose uptake and glucose oxidation. Administration of prednisolone produced opposite changes to dexamethasone; that is binding was increased and rates of basal and insulin stimulated deoxyglucose uptake and glucose oxidation were also increased. In contrast to these opposite effects of the two steroids in vivo, when incubated with adipocytes in vitro, prednisolone and dexamethasone had similar effects. Thus, insulin binding was not altered, while rates of basal and insulin stimulated deoxyglucose uptake and glucose oxidation were decreased by both steroids. The finding that administration of dexamethasone decreases insulin binding to adipocytes is in agreement with previous reports. Thus, it has been demonstrated that dexamethasone treatment of rats reduces insulin binding to adipocytes and hepatocytes [6] and liver plasma membranes [7] . In addition, the finding of increased insulin binding to adipocytes from rats treated with prednisolone is consistent with the report of Beck-Nielsen et al. [8] who demonstrated that administration of prednisone (which is rapidly converted to prednisolone) in man increases insulin binding to circulating monocytes. Table 1 shows that dexamethasone treatment led to an increase, whereas prednisolone led to a decrease in the plasma insulin level. Since it is well-known that the circulating insulin level can inversely regulate cellular insulin receptor number [20] , it is possible that the changes in vivo in insulin receptors were secondary to the alterations in plasma insulin concentration. However, it is also possible that changes in receptor number led to the differences in insulin levels, and, at any rate, it is difficult to assign sequential cause and effect relationships in this type of in vivo study.
It is generally accepted that glucocorticoid administration decreases peripheral glucose utilization (for review see [5] ). The finding that dexamethasone decreases basal and insulin stimulated glucose transport and oxidation is therefore consistent with this view. Furthermore, this effect of dexamethasone administration on adipocyte metabolism has been described previously [15] . However, we have demonstrated that acute administration of prednisolone in vivo has the opposite effect, suggesting that this cornpound may have the seemingly paradoxical effect of enhancing overall glucose disposal in vivo. Indeed, some support for this notion can be found in the literature. Thus, Issekutz and co-workers studied the metabolic clearance rate of glucose in vivo by radiolabeled glucose infusion techniques in dogs [21, 22] . Their results indicate that methylprednisolone treatment leads to a 70% increase in overall glucose uptake.
When incubated with adipocytes in vitro, both dexamethasone and prednisolone decreased basal and insulin stimulated glucose transport and oxidation. However, both steroids were without effect on insulin binding to cells. Thus, it seems that the increase in glucose utilization by adipocytes isolated from rats treated with prednisolone is not a direct effect of the steroid on the cells, but must be mediated by some secondary factor resulting from prednisolone administration in vivo. Additionally, the potency of this effect must be significant, since it over-rides the direct action of prednisolone to decrease glucose transport and oxidation in vitro. Although it is possible that different doses of these glucocorticoids or different lengths of administration might lead to other comparative effects, it is clear that under these experimental conditions prednisolone and dexamethasone have opposite effects. Whatever the mechanism of these effects, it is important to note that our results show that chemically similar glucocorticoid preparations can lead to divergent metabolic actions.
Impaired glucose tolerance following glucocorticoid therapy is a well documented phenomenon [23] and prednisolone also causes this effect [24] . Theoretically, this decrease in glucose tolerance can be due to a combination of decreased glucose utilization and of increased hepatic glucose production [5] . For glucocorticoids which exert their effects as dexamethasone does, it is probable that both decreased glucose uptake and increased hepatic glucose production are operative factors. On the other hand, our results suggest that prednisolone increases peripheral glucose utilization, indicating that increased hepatic glucose production is the mechanism whereby prednisolone causes intolerance.
